The-netherlands?p=21712 Latest Articles
Life Sciences and Healthcare
EU court issues significant decision on pharma-device 'borderline' product case
European ruling clarifies the definition of pharmacological action for health products
24/04/2025
Read time
4m
Dispute resolution
Third party litigation funding in Europe: is regulation on the cards?
Both the EU and the UK are currently reviewing their current positions on litigation funding
23/04/2025
Read time
5m
Decarbonisation
What is the current state of the European hydrogen investment landscape?
Challenges can be overcome using a combination of enabling infrastructure and facilitative policy
17/04/2025
Read time
4m
Tax
Pillar 2 and M&A transactions: navigating the new Global Minimum Tax regime
This article, by Osborne Clarke partner Esther Villa, was adapted from an article first published in the International Tax Review on 4 April 2025
16/04/2025
Read time
5m
